149 related articles for article (PubMed ID: 30809094)
1. Prognostic implications of MYBL2 in resected Chinese gastric adenocarcinoma patients.
Jia Y; Gao Y; Li J; Chang Z; Yan J; Qin Y
Onco Targets Ther; 2019; 12():1129-1135. PubMed ID: 30809094
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma.
Yu R; Li C; Lin X; Chen Q; Li J; Song L; Lin L; Liu J; Zhang Y; Kong W; Ouyang X; Chen X
Pathol Res Pract; 2017 Aug; 213(8):964-968. PubMed ID: 28559119
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of
Sun SS; Fu Y; Lin JY
Oncol Lett; 2020 Apr; 19(4):2765-2772. PubMed ID: 32218829
[TBL] [Abstract][Full Text] [Related]
4. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma.
Tang HR; Luo XQ; Xu G; Wang Y; Feng ZJ; Xu H; Shi YW; Zhang Q; Wu LG; Xue CQ; Wang CW; Wu CY
World J Gastroenterol; 2012 Dec; 18(48):7319-26. PubMed ID: 23326140
[TBL] [Abstract][Full Text] [Related]
5. MYBL2 is an independent prognostic marker that has tumor-promoting functions in colorectal cancer.
Ren F; Wang L; Shen X; Xiao X; Liu Z; Wei P; Wang Y; Qi P; Shen C; Sheng W; Du X
Am J Cancer Res; 2015; 5(4):1542-52. PubMed ID: 26101717
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma.
Qin H; Li Y; Zhang H; Wang F; He H; Bai X; Li S
Onco Targets Ther; 2019; 12():1917-1927. PubMed ID: 30881043
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype.
De Franco L; Marrelli D; Voglino C; Vindigni C; Ferrara F; Di Mare G; Iudici L; Marini M; Roviello F
Pathol Oncol Res; 2018 Apr; 24(2):393-400. PubMed ID: 28555306
[TBL] [Abstract][Full Text] [Related]
8. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
9. MYBL2 is a Novel Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Prostate Cancer.
Jiao M; Zhang F; Teng W; Zhou C
Int J Gen Med; 2022; 15():3003-3030. PubMed ID: 35313552
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
11. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and association of Lauren classification with VEGF and VEGFR-2 expression in gastric cancer.
Li X; Zhu X; Wang Y; Wang R; Wang L; Zhu ML; Zheng L
Oncol Lett; 2019 Nov; 18(5):4891-4899. PubMed ID: 31611999
[TBL] [Abstract][Full Text] [Related]
13. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
14. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
15. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
18. MYBL2 is a Potential Prognostic Marker that Promotes Cell Proliferation in Gallbladder Cancer.
Liang HB; Cao Y; Ma Q; Shu YJ; Wang Z; Zhang F; Ye YY; Li HF; Xiang SS; Song XL; Xu Y; Zhang YC; Bao RF; Yuan RY; Zhang YJ; Hu YP; Jiang L; Li ML; Wang XA; Wu XS; Wu WG; Zhao S; Fand Y; Cui XP; Lu YS; Zhou J; Zheng L; Gong W; Liu YB
Cell Physiol Biochem; 2017; 41(5):2117-2131. PubMed ID: 28427077
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of C/EBP homologous protein (CHOP) in advanced gastric cancer.
Zhang X; Zhou T; Li W; Zhang T; Che N; Zu G
Pathol Res Pract; 2018 Aug; 214(8):1105-1109. PubMed ID: 29910063
[TBL] [Abstract][Full Text] [Related]
20. PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer.
He Q; Ding Z; Chen T; Wu H; Song J; Xiang Z; Yang C; Wang S; Xiong B
Front Oncol; 2023; 13():1164070. PubMed ID: 37538116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
